SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-015374
Filing Date
2023-05-04
Accepted
2023-05-04 07:20:55
Documents
76
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 621209
2 ex10-4.htm EX-10.4 29030
3 ex31-1.htm EX-31.1 19205
4 ex31-2.htm EX-31.2 18839
5 ex32-1.htm EX-32.1 7119
6 ex32-2.htm EX-32.2 7273
  Complete submission text file 0001493152-23-015374.txt   3908714

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE xtnt-20230331.xsd EX-101.SCH 31122
8 XBRL CALCULATION FILE xtnt-20230331_cal.xml EX-101.CAL 64853
9 XBRL DEFINITION FILE xtnt-20230331_def.xml EX-101.DEF 110300
10 XBRL LABEL FILE xtnt-20230331_lab.xml EX-101.LAB 286424
11 XBRL PRESENTATION FILE xtnt-20230331_pre.xml EX-101.PRE 225527
70 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 440853
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 23886455
SIC: 2836 Biological Products, (No Diagnostic Substances)